Change in Gait Deviation Index after anti-tumour necrosis factor-α treatment in individuals with rheumatoid arthritis: a pilot study

By Broström EW   Esbjörnsson A-C   Heideken J von   Larsson P   Wretenberg P   Iversen M  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 5, 2013-10 ,pp. : 356-361

Informa Healthcare

Access to resources Recommend Favorite

Potential Effect of Anti-Tumour Necrosis Factor-Alpha Treatment on Reducing the Cardiovascular Risk Related to Rheumatoid Arthritis

By  

Current Vascular Pharmacology, Vol. 8, Iss. 2, 2010-01 ,pp. : 285-292

Bentham Science Publishers

Access to resources Recommend Favorite

Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors

By Kita Junko  

Modern Rheumatology, Vol. 22, Iss. 2, 2012-04 ,pp. : 195-201

Springer Publishing Company

Access to resources Recommend Favorite

Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?

By Nagashima Takao   Minota Seiji  

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 819-820

Springer Publishing Company

Access to resources Recommend Favorite

Staphylococcus aureus thymic abscesses associated with anti-tumour necrosis factor therapy

By Osiri M.   Tantawichien T.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 4, 2007-01 ,pp. : 320-321

Informa Healthcare

Access to resources Recommend Favorite